EyePoint (EYPT) Amortizatization of Intangibles (2010 - 2021)
EyePoint (EYPT) posted Amortizatization of Intangibles of $166000.0 for Q4 2021, up 2.47% sequentially from $162000.0 in Q3 2021, and down 21.33% YoY from $211000.0 in Q4 2020.
Powered by 
Analysis
EyePoint (EYPT) Amortizatization of Intangibles (2010 - 2021) Analysis & Trends
EyePoint has reported Amortizatization of Intangibles for 11 years, with the latest figure at $166000.0 in Q4 2021.
- Quarterly Amortizatization of Intangibles fell 21.33% year-over-year to $166000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $628000.0 (down 15.7% YoY) and the FY2021 annual result came in at $628000.0, down 15.7% from the prior year.
- Amortizatization of Intangibles climbed to $166000.0 in Q4 2021 per EYPT's latest filing, from $162000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $211000.0 in Q4 2020 and troughed at -$2000.0 in Q1 2017.
- A 4-year average of $147000.0 and a median of $162000.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2017 and 2020: Amortizatization of Intangibles tumbled 111.11% in 2017, then jumped 103.57% in 2020.
- Over 4 years, Amortizatization of Intangibles stood at -$2000.0 in 2017, then soared by 8400.0% to $166000.0 in 2019, then advanced by 27.11% to $211000.0 in 2020, then fell by 21.33% to $166000.0 in 2021.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $166000.0, $162000.0, and $153000.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 166,000.00 |
| Sep 30, 2021 | 162,000.00 |
| Jun 30, 2021 | 153,000.00 |
| Mar 31, 2021 | 147,000.00 |
| Dec 31, 2020 | 211,000.00 |
| Sep 30, 2020 | 186,000.00 |
| Jun 30, 2020 | 177,000.00 |
| Mar 31, 2020 | 171,000.00 |
| Dec 31, 2019 | 166,000.00 |
| Sep 30, 2019 | 160,000.00 |
| Jun 30, 2019 | 130,000.00 |
| Mar 31, 2019 | 84,000.00 |
| Mar 31, 2017 | -2,000.00 |
| Dec 31, 2016 | -2,000.00 |
| Sep 30, 2016 | -5,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Mar 31, 2016 | 18,000.00 |
| Dec 31, 2015 | 34,000.00 |
| Sep 30, 2015 | 34,000.00 |
| Jun 30, 2015 | 32,000.00 |